Enteric Disease Testing Market Overall Study Report 2021-2028 | Alere, Inc., Becton Dickinson & Company, Biomerica, Inc., bioMerieux, Bio-Rad

Intestinal infections in enteric diseases can cause a variety of symptoms ranging from asymptomatic to severe, such as vomiting, abdominal cramps, anorexia, and nausea. Extreme symptoms and clinical signs, in some cases, can even result in death due to a large loss of fluids and important nutrients from the body.

Request Here For PDF Brochure With Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/1164

Statistics

By the end of 2020, the global enteric disease testing market is expected to be worth US$ 3,732.7 Million.

Global Enteric Disease Testing Market: Drivers
During the forecast period, the high prevalence of typhoid fever is expected to drive the global enteric disease testing market growth. For instance, according to the research 'The global burden of typhoid and paratyphoid fevers: a systematic analysis for the Global Burden of Disease Study 2017', which was published in February 2019, 14 million cases of typhoid and paratyphoid fevers occurred globally in 2017.

Global Enteric Disease Testing Market:
Opportunities

New method R&D is expected to provide attractive growth opportunities for companies in the global enteric disease testing market. For instance, in August 2020, researchers at Purdue University in the U.S. announced the development of a novel 3D-printed capsule that permits samples of the gut bacteria for further study and probable disease diagnosis.

Global Enteric Disease Testing Market: Restraints

Low public health spending, particularly in emerging nations, is expected to restrict the global enteric disease testing market growth.

Get Sample Report With Latest Covid19 Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/1164

Key takeaways:

The global enteric disease testing market was worth US$ 3,643.4 million in 2019 and is expected to reach US$ 4,432.7 million by 2027, growing at a CAGR of 2.5 % during the forecast period 2020-2027.

During the forecast period, the high prevalence of typhoid fever is expected to drive the global enteric disease testing market growth.
Market trends
R&D in enteric infections is expected to drive the global enteric disease testing market growth during the forecast period. For instance, researchers from the University of Texas Southwestern Medical Center in the US reported in June 2020 that l-arginine sensing helps regulate virulence gene expression and disease progression in enteric pathogens.

Furthermore, the use of satellite observations in disease models is expected to propel market growth. Earth-observing satellites can be used by researchers to evaluate when and where particular illnesses would develop and spread.
Global Enteric Disease Testing Market: Competitive landscape

Some of the key players contributing to the global enteric disease testing market are Quest Diagnostics, Biomerica, Inc., DiaSorin, Becton Dickinson & Co., Meridian Bioscience, Inc., Bio-Rad, Trinity Biotech, Cepheid, bioMerieux, Coris BioConcept, and Alere, Inc.

Global Enteric Disease Testing Market: Key Developments

Key players operating in the global enteric disease testing market are concentrating on getting new products approved and launched to increase their product line. For instance, Becton, Dickinson, and Co. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) in December 2018 for its BD Max enteric viral panel, a molecular diagnostic test for the detecting and distinction of virus that causes viral gastroenteritis.

Purchase This Premium Report To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/1164

View More Reports

Interstitial Cystitis Drugs Market - https://www.coherentmarketinsights.com/market-insight/interstitial-cystitis-drugs-market-4488

Pain Management Therapeutics Market - https://www.coherentmarketinsights.com/press-release/pain-management-therapeutics-market-3878

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

This release was published on openPR.